Icosapent ethyl with statin therapy for reducing the risk of cardiovascular events in people with raised triglycerides

  • Technology appraisal guidance
  • TA805
  • Published: 

Evidence

Documents containing the evidence that was used to develop the recommendations.

Supporting evidence